Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 11Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 2Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Platinum-resistant Ovarian Cancer 1Pancreatic Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Nausea 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Kenny-Caffey syndrome, Type 1 1Gonadal Disorders 1Glioblastoma 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Neoplasms 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1

Interventions

Cisplatin 10Paclitaxel 9Radiotherapy 5Fluorouracil 5Radiotherapy, Intensity-Modulated 4Docetaxel 4Carboplatin 4advexin 2Therapeutics 2Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Drug Therapy 2Cetuximab 2Afatinib 2penpulimab 1pembrolizumab 1olaparib 1niraparib 1nimotuzumab 1nedaplatin 1durvalumab 1daromun 1camrelizumab 1calcipotriene 1atezolizumab 1afamelanotide 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Squamous Cell × niraparib × Clear all
NCT03221400 2022-02-17

PEN-866 in Patients With Advanced Solid Malignancies

Tarveda Therapeutics

Phase 1/2 Unknown
340 enrolled
GastrointestinalThoracic

Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡